Isolated central nervous system relapse of non-seminomatous germ cell tumour of the testis. A case report and review of the literature

Oncology. 2001;61(3):184-8. doi: 10.1159/000055372.

Abstract

Isolated central nervous system (CNS) relapse of non-seminomatous germ cell tumour (NSGCT) of the testis has been reported in only 12 patients previously. We report a patient with an isolated CNS relapse of NSGCT, following a prior systemic relapse. From a review of previous cases, isolated CNS relapse appears to be more common in patients with embryonal cell histology (alone or mixed with other elements) and occurred after a median of 8.5 months following initial presentation. Long-term survival appears possible using multi-modal treatment with whole-brain radiotherapy, surgery and/or chemotherapy. However, the optimal treatment of isolated CNS relapse remains undefined.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / analysis
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / surgery
  • Carcinoma, Embryonal / drug therapy
  • Carcinoma, Embryonal / radiotherapy
  • Carcinoma, Embryonal / secondary*
  • Carcinoma, Embryonal / surgery
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Cranial Irradiation
  • Etoposide / administration & dosage
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Lymphatic Metastasis
  • Male
  • Occipital Lobe* / surgery
  • Orchiectomy
  • Radiotherapy, Adjuvant
  • Remission Induction
  • Testicular Neoplasms / pathology*
  • Testicular Neoplasms / surgery
  • Tomography, X-Ray Computed
  • Vision Disorders / etiology
  • alpha-Fetoproteins / analysis

Substances

  • Biomarkers, Tumor
  • alpha-Fetoproteins
  • Etoposide
  • Cisplatin